8X5V image
Entry Detail
PDB ID:
8X5V
Title:
BlCas9-sgRNA-target DNA complex
Biological Source:
PDB Version:
Deposition Date:
2023-11-19
Release Date:
2024-07-10
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.23
R-Value Work:
0.19
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:BlCas9
Chain IDs:A
Chain Length:933
Number of Molecules:1
Biological Source:Brevibacillus laterosporus
Polymer Type:polyribonucleotide
Description:RNA (110-mer)
Chain IDs:B
Chain Length:110
Number of Molecules:1
Biological Source:Brevibacillus laterosporus
Polymer Type:polydeoxyribonucleotide
Description:DNA (28-mer)
Chain IDs:C
Chain Length:28
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polydeoxyribonucleotide
Description:DNA (8-mer)
Chain IDs:D
Chain Length:8
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Structure and engineering of Brevibacillus laterosporus Cas9.
Commun Biol 7 803 803 (2024)
PMID: 38961195 DOI: 10.1038/s42003-024-06422-z

Abstact

The RNA-guided DNA endonuclease Cas9 cleaves double-stranded DNA targets complementary to an RNA guide, and is widely used as a powerful genome-editing tool. Here, we report the crystal structure of Brevibacillus laterosporus Cas9 (BlCas9, also known as BlatCas9), in complex with a guide RNA and its target DNA at 2.4-Å resolution. The structure reveals that the BlCas9 guide RNA adopts an unexpected architecture containing a triple-helix, which is specifically recognized by BlCas9, and that BlCas9 recognizes a unique N4CNDN protospacer adjacent motif through base-specific interactions on both the target and non-target DNA strands. Based on the structure, we rationally engineered a BlCas9 variant that exhibits enhanced genome- and base-editing activities with an expanded target scope in human cells. This approach may further improve the performance of the enhanced BlCas9 variant to generate useful genome-editing tools that require only a single C PAM nucleotide and can be packaged into a single AAV vector for in vivo gene therapy.

Legend

Protein

Chemical

Disease

Primary Citation of related structures